参考文献/References:
[1] Jaffe AS,Ravkilde J,Roberts R,et al. It’s time for a change to a troponin standard[J]. Circulation,2000,102(11):1216-1220.
[2] Thygesen K,Alpert JS,Jaffe AS,et al. Third universal definition of myocardial infarction[J]. Circulation,2012,126(16):2020-2035.
[3] Morrow DA,Cannon CP,Jesse RL,et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines:clinical characteristics and utilization of biochemical markers in acute coronary syndromes[J]. Clin Chem,2007,53(4):552-574.
[4] Shah ASV,Anand A,Strachan FE,et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome:a stepped-wedge,cluster-randomised controlled trial[J]. Lancet,2018,392(10151):919-928.
[5] Chin CW,Shah AS,McAllister DA,et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis[J]. Eur Heart J,2014,35(34):2312-2321.
[6] Shah AS,McAllister DA,Mills R,et al. Sensitive troponin assay and the classification of myocardial infarction[J]. Am J Med,2015,128(5):493-501.
[7] Feldman DN,Minutello RM,Bergman G,et al. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes[J]. Am J Cardiol,2009,104(9):1210-1215.
[8] Fox KA,Carruthers KF,Dunbar DR,et al. Underestimated an under-recognized: the late consequences of acute coronary syndrome(GRACE UK-Belgian Study)[J]. Eur Heart J,2010,31(22):2755-2764.
[9] Wallentin L,Lindhagen L,?rnstr?m E,et al. Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome(FRISC-Ⅱ):15?year follow-up of a prospective,randomised,multicentre study[J]. Lancet,2016,388(10054):1903-1911.
[10] Miller WL,Garratt KN,Burritt MF,et al. Baseline troponin level:key to understanding the importance of post-PCI troponin elevations[J]. Eur Heart J,2006,27(9):1061-1069.
[11] Gravning J,Ueland T,M?rkrid L,et al. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris[J]. Scand Cardiovasc J,2008,42(3):214-221.
[12] Cantor WJ,Newby LK,Christenson RH,et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention[J]. J Am Coll Cardiol,2002,39(11):1738-1744.
[13] Bagai A,Huang Z,Lokhnygina Y,et al. Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization[J]. Circ Cardiovasc Interv,2015,8(6):e002314.
[14] Shugman IM,Diu P,Gohil J,et al. Evaluation of troponin T criteria for periprocedural myocardial infarction in patients with acute coronary syndromes[J]. Am J Cardiol,2011,107(6):863-870.
[15] Tricoci P,Leonardi S,White J,et al. Cardiac troponin afte percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends[J]. J Am Coll Cardiol,2013,62(3):242-251.
[16] Damman P,Beijk MA,Kuijt WJ,et al. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction[J]. J Am Coll Cardiol,2011,57(1):29-36.
[17] Hassan AK,Bergheanu SC,Hasan-Ali H,et al. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention[J]. Am J Cardiol,2009,103(6):779-784.
[18] Ndrepepa G,Kufner S,Hoyos M,et al. High-sensitivity cardiac troponin T and prognosis in patients with ST-segment elevation myocardial infarction[J]. J Cardiol,2018,72(3):220-226.
[19] Antoni ML,Hoogslag GE,Boden H,et al. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention(Data from the Leiden MISSION! Infarct Registry)[J]. Am J Cardiol,2012,109(2):187-194.
[20] Bonello L,de Labriolle A,Lemesle G,et al. Prognostic value of procedure-related myocardial infarction according to the universal definition of myocardial infarction in saphenous vein graft interventions[J]. Am Heart J,2009,157(5):894-898.
[21] Brunetti ND,Quagliara D,di Biase M. Troponin ratio and risk stratification in subjects with acute coronary syndrome undergoing percutaneous coronary intervention[J]. Eur J Intern Med,2008,19(6):435-442.
[22] Lacalzada J,de la Rosa A,Izquierdo MM,et al. Left ventricular global longitudinal systolic strain predicts adverse remodeling and subsequent cardiac events in patients with acute myocardial infarction treated with primary percutaneous coronary intervention[J]. Int J Cardiovasc Imaging,2015,31(3):575-584.
[23] Leutner M,Tscharre M,Farhan S,et al. A sex-specific analysis of the predictive value of troponin I and T in patients with and without diabetes mellitus after successful coronary intervention[J]. Front Endocrinol,2019,10:105
[24] Park SJ,Park JH,Lee HS,et al. Impaired RV global longitudinal strain is associated with poor long-term clinical outcomes in patients with acute inferior STEMI[J]. JACC Cardiovasc Imaging,2015,8(2):161-169.
[25] McKie PM,AbouEzzeddine OF,Scott CG,et al. High-sensitivity troponin I and amino-terminal pro–B-type natriuretic peptide predict heart failure and mortality in the general population[J]. Clin Chem,2014,60(9):1225-1233.
[26] deFilippi CR,de Lemos JA,Christenson RH,et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults[J]. JAMA,2010,304(22):2494-502.
[27] Pastormerlo LE,Agazio A,Benelli E,et al. Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with heart failure[J]. Am J Cardiol,2015,116(4):567-572.
相似文献/References:
[1]田晶,张青,张岩波,等.慢性心力衰竭结局评价指标研究进展[J].心血管病学进展,2019,(6):931.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.023]
TIAN Jing,ZHANG qing,ZHANG Yanbo,et al.Outcome Indicators for Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2019,(9):931.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.023]
[2]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(9):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[3]于子凯 许海燕 刘庆荣 吴永健.合并常见疾病对经导管主动脉瓣置换术患者预后的影响[J].心血管病学进展,2019,(5):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
YU Zikai,XU Haiyan,LIU Qingrong,et al.Influence of ommon Accompanied Diseases on Prognosis of Patients after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2019,(9):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
[4]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(9):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[5]陈文浩 张焕基 郭攸胜 张东辉.活检证实病毒性心肌炎的治疗策略及预后[J].心血管病学进展,2019,(5):813.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.037]
Chen WenhaoZhang HuanjiGuo YoushengZhang Donghui.Treatment Strategy and Prognosis of Viral Myocarditis Confirmed by Biopsy[J].Advances in Cardiovascular Diseases,2019,(9):813.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.037]
[6]王振伟 王涟 徐标.应激性心肌病患者临床特点及预后分析[J].心血管病学进展,2019,(5):831.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.041]
WANG Zhenwei,WANG Lian,XU Biao.Clinical Features and Prognosis of Patients with Takotsubo Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(9):831.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.041]
[7]吕俊兴 许海燕.急性冠脉综合征危险评分的研究进展[J].心血管病学进展,2019,(9):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
LU Junxing,XU Haiyan.Risk Scores of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(9):1224.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.010]
[8]程宏基 黄裕立 黄伟俊 李美君 童辉煜 申常造 谭宽 蔡福生 胡允兆.入院血糖水平不同的分组方法对急性心力衰竭患者远期预后影响的比较[J].心血管病学进展,2019,(9):1323.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.035]
CHENG Hongji,HUANG Yuli,HUANG Weijun,et al.Effect of Different Admission Blood Glucose Grouping Methods on the Prognosis of Acute Heart Failure Patients[J].Advances in Cardiovascular Diseases,2019,(9):1323.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.035]
[9]罗正丽 李东泽 贾禹 陈力 万智.急性胸痛早期危险分层的研究进展[J].心血管病学进展,2020,(1):39.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.011]
LUO Zh engli,LI Dongze,JIA Yu,et al.Early Risk Stratification of Acute Chest Pain[J].Advances in Cardiovascular Diseases,2020,(9):39.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.011]
[10]刘壮壮 黄宇理.心力衰竭生物标志物的研究进展[J].心血管病学进展,2020,(1):67.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.018]
LIU Zhuangzhuang,HUANG Yuli.Biomarkers for Heart Failure[J].Advances in Cardiovascular Diseases,2020,(9):67.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.018]